Skip to main content

Ju Young Shin

Sungkyunkwan University · 医学

研究室紹介

Professor Ju Young Shin's research lab specializes in pharmacoepidemiology and health informatics, focusing on drug safety, adverse drug reactions, and the long-term health outcomes associated with chronic disease treatments. The lab conducts large-scale, population-based cohort studies using national claims databases to evaluate the risks and benefits of medications, particularly in vulnerable populations such as children with ADHD, patients with diabetes, and individuals post-COVID-19. Key research directions include cardiovascular safety of psychotropic drugs, drug interactions, and the immunomodulatory effects of infections and medications on autoimmune and metabolic diseases. The lab emphasizes real-world evidence to inform clinical decision-making and public health policy.

pharmacoepidemiologydrug safetypopulation-based cohortreal-world evidencechronic disease

Research Overview

Papers
447
Total Citations
4,984
Papers (5y)
216
Primary Field
医学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
216total
2022
2023
2024
2025
2026
Citations per year (5y)
1,510total
20222023202420252026

Selected Papers

15
1
Article|119 citations·2016
Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study
Ju‐Young Shin, Elizabeth E. Roughead, Byung‐Joo Park, Nicole Pratt
SJR Q1BMJOA

The relative risk of myocardial infarction and arrhythmias is increased in the early period after the start of methylphenidate treatment for ADHD in children and young people. Though the absolute risk is likely to be low, the risk-benefit balance of methylphenidate should be carefully considered, particularly in children with mild ADHD.

Psychiatry and Mental healthMedicine
2
Article|95 citations·2015
Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs: nationwide propensity score matched study
Ju‐Young Shin, Mi-Ju Park, Shin Haeng Lee, So‐Hyun Choi, Mi-Hee Kim, Nam‐Kyong Choi, Joongyub Lee, Byung‐Joo Park
SJR Q1BMJOA

Combined use of antidepressants and NSAIDs was associated with an increased risk of intracranial haemorrhage within 30 days of initial combination.

NeurologyMedicine
3
Article|67 citations·2024
Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19
Min Seo Kim, Hayeon Lee, Seung Won Lee, Rosie Kwon, Sang Youl Rhee, Jin A Lee, Ai Koyanagi, Lee Smith, Guillaume Fond, Laurent Boyer, Jinseok Lee, Masoud Rahmati
SJR Q1Annals of Internal Medicine

BACKGROUND: Some data suggest a higher incidence of diagnosis of autoimmune inflammatory rheumatic diseases (AIRDs) among patients with a history of COVID-19 compared with uninfected patients. However, these studies had methodological shortcomings. OBJECTIVE: To investigate the effect of COVID-19 on long-term risk for incident AIRD over various follow-up periods. DESIGN: Binational, longitudinal, propensity-matched cohort study. SETTING: Nationwide claims-based databases in South Korea (K-COV-N

Infectious DiseasesMedicine
4
Article|66 citations·2021
Adherence and Associated Factors of Treatment Regimen in Drug-Susceptible Tuberculosis Patients
Sungho Bea, Hyesung Lee, Ju Hwan Kim, Seung Hun Jang, Hyunjin Son, Jin‐Won Kwon, Ju‐Young Shin
SJR Q1Frontiers in PharmacologyOA

Background: Adherence to tuberculosis (TB) drugs is one of the key aspects of global TB control, yet there is a lack of epidemiological evidence on the factors influencing adherence to TB drugs. Thus, this study aimed to explore the adherence and factors associated with adherence among TB patients in South Korea. Methods: We conducted a cohort study using a sampled national healthcare database from 2017 to 2018. Our study population included incident TB patients initiating quadruple or triple re

EpidemiologyMedicine
5
Article|61 citations·2021
Association of mental disorders with SARS-CoV-2 infection and severe health outcomes: nationwide cohort study
Ha‐Lim Jeon, Jun Soo Kwon, Sohee Park, Ju‐Young Shin
SJR Q1The British Journal of PsychiatryOA

BACKGROUND: Epidemiological data on the association between mental disorders and the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) severity are limited. AIMS: To evaluate the association between mental disorders and the risk of SARS-CoV-2 infection and severe outcomes following COVID-19. METHOD: We performed a cohort study using the Korean COVID-19 patient database based on national health insurance data. Each person with a

Molecular BiologyBiochemistry, Genetics and Molecular Biology
6
Article|61 citations·2023
Risk of thyroid cancer associated with glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: A population‐based cohort study
Sungho Bea, Heejun Son, Jae Hyun Bae, Sun Wook Cho, Ju‐Young Shin, Young Min Cho
SJR Q1Diabetes Obesity and Metabolism

AIMS: To determine the potential association between the use of either glucagon-like peptide-1 receptor agonists (GLP-1RAs) or dipeptidyl peptidase-4 (DPP-4) inhibitors, and the risk of thyroid cancer in individuals with type 2 diabetes. MATERIALS AND METHODS: This population-based cohort study used claims data from the Korean National Health Insurance Database, 2014-2020. Two distinct cohorts were established to compare each incretin-based drug with sodium-glucose cotransporter-2 (SGLT2) inhibi

Endocrinology, Diabetes and MetabolismMedicine
7
Article|58 citations·2020
Gender differences in adverse event reports associated with antidiabetic drugs
Kyung-In Joung, Gyu-Won Jung, Han-Heui Park, Hyesung Lee, Sohee Park, Ju‐Young Shin
SJR Q1Scientific ReportsOA

Little is known about gender-specific reporting of adverse events (AEs) associated with antidiabetic drugs. This study was to assess the gender-related difference in AEs reporting associated with antidiabetic agents. The number of antidiabetic drug-AE pairs associated was identified using the Korea Adverse Event Reporting System database. Prevalence of diabetes was estimated using the Health Insurance Review and Assessment Service-National Patients Sample database. Reporting rate per 10,000 peop

ToxicologyPharmacology, Toxicology and Pharmaceutics
8
Review|54 citations·2024
Global prevalence of functional dyspepsia according to Rome criteria, 1990–2020: a systematic review and meta-analysis
Kwanjoo Lee, Chang‐Il Kwon, Abdullah Özgür Yeniova, Ai Koyanagi, Louis Jacob, Lee Smith, Seung Won Lee, Masoud Rahmati, Ju‐Young Shin, Jae Il Shin, Wonyoung Cho, Dong Keon Yon
SJR Q1Scientific ReportsOA

Although functional dyspepsia (FD) is a common functional gastroduodenal disorder with a high socioeconomic burden, little is known about its global prevalence. Thus, we performed a comprehensive study to estimate long-term trends in the prevalence of FD. We searched PubMed/MEDLINE, Embase, and Google Scholar from 1990 to 2022 for population-based studies that reported the prevalence of FD in adults (≥ 18 years old) according to Rome I, II, III, or IV criteria. The prevalence of FD was extracted

SurgeryMedicine
9
Article|52 citations·2013
Risk of ischemic stroke with the use of risperidone, quetiapine and olanzapine in elderly patients: a population-based, case-crossover study
Ju‐Young Shin, Nam‐Kyong Choi, Sun‐Young Jung, Joongyub Lee, Jun Soo Kwon, Byung‐Joo Park
SJR Q1Journal of Psychopharmacology

We conducted a case-crossover study to evaluate the comparative risk of ischemic stroke associated with the use of risperidone, quetiapine and olanzapine in geriatric patients using the Korean Health Insurance Review and Assessment Service database. Cases included elderly patients >64 years old who had experienced their first ischemic stroke (International Classification of Disease, Tenth Revision (ICD-10), I63) hospitalization from July 2005 to June 2006 and who had been without prior cerebrova

Psychiatry and Mental healthMedicine
10
Article|49 citations·2019
Incidence of skeletal-related events in patients with breast or prostate cancer-induced bone metastasis or multiple myeloma: A 12-year longitudinal nationwide healthcare database study
Yeon‐Hee Baek, Ha‐Lim Jeon, In‐Sun Oh, Hyowon Yang, Jeehye Park, Ju‐Young Shin
SJR Q1Cancer Epidemiology
OncologyMedicine
11
Article|48 citations·2024
Risk of hepatic events associated with use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists, and thiazolidinediones among patients with metabolic dysfunction-associated steatotic liver disease
Sungho Bea, Hwa Yeon Ko, Jae Hyun Bae, Young Min Cho, Yoosoo Chang, Seungho Ryu, Christopher D. Byrne, Ju‐Young Shin
SJR Q1GutOA

OBJECTIVE: To examine the hepatic effectiveness of sodium-glucose cotransporter-2 inhibitors (SGLT-2i) through a head-to-head comparison with glucagon-like peptide-1 receptor agonists (GLP-1RA) or thiazolidinediones (TZD) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). DESIGN: This population-based cohort study was conducted using a nationwide healthcare claims database (2014-2022) of Korea. We included individuals with MASLD (aged ≥40 years) who initiated SGLT

Endocrinology, Diabetes and MetabolismMedicine
12
Article|47 citations·2022
First-trimester exposure to benzodiazepines and risk of congenital malformations in offspring: A population-based cohort study in South Korea
Yunha Noh, Hyesung Lee, Ahhyung Choi, Jun Soo Kwon, Seung‐Ah Choe, Jungmi Chae, Dong‐Sook Kim, Ju‐Young Shin
SJR Q1PLoS MedicineOA

BACKGROUND: Benzodiazepines are frequently prescribed during pregnancy; however, evidence about possible teratogenicity is equivocal. We aimed to evaluate the association between first-trimester benzodiazepine use and the risk of major congenital malformations. METHODS AND FINDINGS: Using Korea's nationwide healthcare database, we conducted a population-based cohort study of women who gave birth during 2011 to 2018 and their live-born infants. The exposure was defined as one or more benzodiazepi

Public Health, Environmental and Occupational HealthMedicine
13
Article|45 citations·2021
Survival outcomes of patients with nonsmall cell lung cancer concomitantly receiving proton pump inhibitors and immune checkpoint inhibitors
Yeon‐Hee Baek, Eun Joo Kang, Soojung Hong, Sohee Park, Ju Hwan Kim, Ju‐Young Shin
SJR Q1International Journal of CancerOA

Abstract Recent evidence suggests that gut microbiota dysbiosis adversely affects the efficacy of immune checkpoint inhibitors (ICIs). Our objective was to investigate the association between concomitant use of proton pump inhibitors (PPIs) and ICIs, and poor prognosis in patients with nonsmall cell lung cancer (NSCLC). We conducted a cohort study using a completely enumerated lung cancer cohort from a nationwide healthcare database in South Korea. We identified 2963 patients treated with ICIs a

OncologyMedicine
14
Article|44 citations·2014
New initiatives for pharmacovigilance in South Korea: introducing the Korea Institute of Drug Safety and Risk Management (KIDS)
Ju‐Young Shin, Sun-Young Jung, So-Hyeon Ahn, Shin Haeng Lee, Sujin Kim, Jong-Mi Seong, Soo-Youn Chung, Byung‐Joo Park
SJR Q1Pharmacoepidemiology and Drug Safety

The KIDS will continue to contribute to the improvement of Korean pharmacovigilance by collecting, managing, and analyzing consumer-centered drug safety information.

ToxicologyPharmacology, Toxicology and Pharmaceutics
15
Article|42 citations·2017
Health Care Utilization and Direct Costs in Mild, Moderate, and Severe Adult Asthma: A Descriptive Study Using the 2014 South Korean Health Insurance Database
Yoo Ju Lee, Sun‐Hong Kwon, Sung-Hyun Hong, Jin Hyun Nam, Hyun Jin Song, Jong Seop Lee, Eui‐Kyung Lee, Ju‐Young Shin
SJR Q1Clinical Therapeutics
PhysiologyMedicine

Research Areas

EpidemiologyToxicologyEndocrinology, Diabetes and MetabolismPublic Health, Environmental and Occupational HealthInfectious DiseasesPsychiatry and Mental health

Ju Young Shinの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。